ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Delivering Market Success For Pharma Partners From Concept To Patient

  The development of drug delivery devices that are innovative, intuitive, patient friendly, and patient safe must address certain areas of concern that are particular to both biologic and biosimilar therapies.

• Deploying A Circular Economy For Medical Devices

  A circular economy prioritizes sustainability throughout the supply chain by eliminating waste, circulating products and materials, and regenerating nature.

• Streamline Microbial Process Development To Reach Toxicology Trials Faster

  For biopharmas looking to outsource their early phase development, consider working with a CDMO partner that has the knowledge and experience to navigate microbial fermentation and complex process development.

• Key Considerations When Filling Dual Chamber Syringes

  Dual-chamber syringes (DCSs) are in high demand across the pharmaceutical and hospital industries. Learn about the challenges of the DCS filling manufacturing market and how to overcome them.

• Why 'Off-The-Shelf' Devices Do Not Circumvent Design Controls

  Utilizing off-the-shelf (OTS) devices for drug delivery can offer significant advantages to development programs in timeline and risk mitigation. Understand the design control responsibilities of a sponsor when using OTS devices.

• Characterizing The E&L Profile Of Stoppers For Drug Stability

  The significance of E&L testing lies in its ability to identify potential risks associated with the use of containers and packaging materials in the pharmaceutical industry.

• Promising Early Results For New High-Performance DPI

  This report discusses the benefits of the αeolus technology, a passive, high-performance, high-consistency dry powder inhaler platform concept, and the preliminary performance data from early-stage development.

• The Path To Commercialization For Wearable Drug Delivery Devices

  Explore the evolution of the wearable drug delivery market, including the route to commercialization and the challenges faced.

• Single Source Partner: Seamless Approach To Deliver World-Class Treatment

  Growing demand for high-value, complex therapies requires the right containment and delivery systems: solutions that offer superior quality and patient comfort while meeting stringent regulatory requirements. 

• Small Is Powerful And Sustained

  Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance.